Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Avlar BioVentures

Founders Alan G. Goodman

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 8
Rounds per year 0.68
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.47
Exits 1
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
  • Health Care
  • Pharmaceutical
Summary

Avlar BioVentures is the famous VC, which was founded in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Madingley.

Considering the real fund results, this VC is 7 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2005. This Avlar BioVentures works on 22 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars.

The current fund was established by Alan G. Goodman. We also calculated 2 valuable employees in our database.

The standard case for the fund is to invest in rounds with 3 partakers. Despite the Avlar BioVentures, startups are often financed by Excalibur Fund Managers, UK Innovation & Science Seed Fund, Scottish Equity Partners. The meaningful sponsors for the fund in investment in the same round are Excalibur Fund Managers, UK Innovation & Science Seed Fund, Providence Investment Company Limited. In the next rounds fund is usually obtained by Excalibur Fund Managers, UK Innovation & Science Seed Fund, Scottish Equity Partners.

For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Crescendo Biologics, Purely Proteins Limited, Takeda Cambridge. Among the most popular fund investment industries, there are Health Care, Software. The fund has specific favorite in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Avlar BioVentures:
Typical Co-investors
Avlar BioVentures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Avlar BioVentures:

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anzhuoxin Venture Capital China, Guangdong Province, Huizhou
Apothecary Capital Chicago, Illinois, United States
Bialla Venture Partners Maryland, Severna Park, United States
Greenhouse Capital Partners California, Sausalito, United States
Manitou Ventures California, San Francisco, United States
MegaChips Japan, Osaka, Osaka Prefecture
Raised In Space Enterprises California, Santa Monica, United States
Rhiza Capital / Sunshine Coast Venture Partners -
Zamagias Properties Inc. Pennsylvania, Pittsburgh, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Crescendo Biologics

Biotechnology
Health Care
Therapeutics
$7M20 Jan 2010 England

Crescendo Biologics

Biotechnology
Health Care
Therapeutics
$6M12 Oct 2009 England

Biotechnology
$3M01 Dec 2004 England

CellCentric

Biotechnology
Medical
Therapeutics
03 Jun 2004 Cambridge, England, United Kingdom

Biotechnology
26 Nov 2003 United Kingdom, England

De Novo Pharmaceuticals

Life Science
Medical
Pharmaceutical
$23M26 Jul 2001 Cambridge, England, United Kingdom

De Novo Pharmaceuticals

Life Science
Medical
Pharmaceutical
$2M18 Apr 2000 United Kingdom, England

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Avlar BioVentures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 15
Average round size 5M
Rounds per year 0.68
Peak activity year 2005
Lead investments 2
Follow on index 0.47
Exits 1
Group Appearance index 0.87

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Crescendo Biologics

Biotechnology
Health Care
Therapeutics
$7M20 Jan 2010 England

Crescendo Biologics

Biotechnology
Health Care
Therapeutics
$6M12 Oct 2009 England

Biotechnology
$3M01 Dec 2004 England

CellCentric

Biotechnology
Medical
Therapeutics
03 Jun 2004 Cambridge, England, United Kingdom

Biotechnology
26 Nov 2003 United Kingdom, England

De Novo Pharmaceuticals

Life Science
Medical
Pharmaceutical
$23M26 Jul 2001 Cambridge, England, United Kingdom

De Novo Pharmaceuticals

Life Science
Medical
Pharmaceutical
$2M18 Apr 2000 United Kingdom, England
Crunchbase icon

Content report

The following text will be sent to our editors: